High testosterone numbers don't mean much without full context

What did @realnicktrigi actually say?

Nick's core argument is that men on TRT obsess over their total testosterone number while ignoring everything else that actually matters. He's right that this is a real problem, and he rattles off a solid list of markers people should track: estrogen, hematocrit, lipids, PSA, liver enzymes, kidney function, and cortisol. He also says that "more testosterone doesn't equal better outcomes" and that chasing high numbers can make health worse. The video ends with a pitch to DM him the word "coach," which is worth flagging.

To be clear about the setup: Nick shows before-and-after images and states he's been on TRT for eight to nine years with a current total testosterone of 942 ng/dL. He's not presenting as a clinician. He's presenting as an experienced user with opinions, and some of those opinions are grounded in real endocrinology.

Does the science back this up?

Mostly, yes. The fixation on total testosterone as a standalone metric is a well-documented clinical problem. Research consistently shows that free testosterone and sex hormone-binding globulin (SHBG) levels are better predictors of symptomatic response than total T alone. Estradiol management, hematocrit monitoring, and cardiovascular markers are all considered standard of care in TRT protocols.

Bhasin et al. (2010, New England Journal of Medicine) established that testosterone trials need to account for multiple physiological endpoints, not just serum levels. A 2018 review by Gagliano-Juca and Basaria in Nature Reviews Endocrinology confirmed that supraphysiologic testosterone is associated with increased cardiovascular risk, erythrocytosis, and sleep apnea. Nick's point that "more testosterone can make your health worse" is not bro-science. It reflects documented dose-dependent risks. His inclusion of cortisol as a tracking marker is less standard in TRT guidelines but not unreasonable given the HPA-HPG axis interaction.

What did they get wrong (or right)?

Nick gets more right than wrong here, which is worth saying plainly. His list of monitoring markers is genuinely solid and reflects current Endocrine Society guidance. His framing that lifestyle symptoms like energy, libido, sleep quality, and mood are meaningful clinical endpoints is accurate. Patient-reported outcomes are increasingly recognized as primary endpoints in hormone therapy research, not secondary noise.

Where he's imprecise: the claim that high testosterone "slows down your progress" is vague and unsupported as stated. Progress toward what? In the context of TRT for hypogonadism, higher-than-physiologic levels don't uniformly slow anything. The risk profile changes, but the mechanism he implies is unclear. He also conflates TRT with steroid use in the opening visual comparison, which muddies the clinical picture considerably. Those are different pharmacological situations with different risk profiles. Showing steroid-era physique as a "before" while discussing TRT is misleading framing, even if unintentional.

The coaching pitch at the end is a commercial call-to-action attached to health advice. That's a pattern worth watching critically.

What should you actually know?

If you're on TRT or considering it, the panel of markers Nick listed is genuinely worth discussing with a prescribing clinician. Total testosterone tells you one thing. A complete picture requires free testosterone, SHBG, estradiol (E2), complete blood count with hematocrit, lipid panel, PSA (if over 40 or at risk), and basic metabolic panel covering liver and kidney function. These are not optional extras. They are standard monitoring requirements under Endocrine Society clinical practice guidelines (Bhasin et al., 2018).

Symptom tracking matters too. A 2021 study by Travison et al. in the Journal of Clinical Endocrinology and Metabolism found that men with identical total testosterone levels reported substantially different symptomatic outcomes, reinforcing that serum numbers alone are poor proxies for how a patient actually feels and functions. The relationship between testosterone levels and wellbeing is not linear, and individual response varies considerably based on receptor sensitivity and baseline health status.

One thing Nick doesn't address: self-directed hormone optimization without physician oversight is not a safe substitute for monitored care, regardless of how many years someone has been doing it.